Latin AmericaPharma From Buyer to Builder: Grupo Insud Bets Argentina Can Manufacture Biologics, Not Just Import Them Argentina’s Grupo Insud is building a biologics platform: mAbxience exports biosimilars across three continents while Sinergium anchors Latin America’s mRNA vaccine sovereignty. By Fernando PafumiSep 14, 20264 Comments
IHME: Global Health Funding Falls Another 5% in 2026 After Hitting Lowest Level Since 2012 Nov 16, 2026
You must be logged in to post a comment.